Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease
Eur Respir J
.
2020 Feb 20;55(2):1901681.
doi: 10.1183/13993003.01681-2019.
Print 2020 Feb.
Authors
Veronica Alfieri
1
2
,
Ernesto Crisafulli
3
4
,
Dina Visca
2
5
,
Wing Ho Chong
6
7
,
Carmel Stock
2
8
,
Letizia Mori
9
,
Angelo de Lauretis
10
,
Vicky Tsipouri
2
,
Felix Chua
2
,
Vasilis Kouranos
2
,
Maria Kokosi
2
,
Charlotte Hogben
2
,
Philip L Molyneaux
2
8
,
Peter M George
2
8
,
Toby M Maher
2
8
,
Alfredo A Chetta
3
,
Piersante Sestini
11
,
Athol U Wells
2
8
,
Elisabetta A Renzoni
2
8
Affiliations
1
Dept of Medicine and Surgery, Respiratory Disease and Lung Function Unit, University of Parma, Parma, Italy veronica.alfieri@unipr.it.
2
Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.
3
Dept of Medicine and Surgery, Respiratory Disease and Lung Function Unit, University of Parma, Parma, Italy.
4
Dept of Medicine, Respiratory Medicine Unit, University of Verona, Verona, Italy.
5
Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy.
6
Dept of Radiology, Tuen Mun Hospital, Hong Kong SAR.
7
Dept of Radiology, Royal Brompton Hospital, London, UK.
8
National Heart and Lung Institute, Imperial College, London, UK.
9
Respiratory Medicine, Northwick Park Hospital, Harrow, UK.
10
Unità Operativa Complessa di Pneumologia, ASST-Rhodese, Garbagnate Milanese, Italy.
11
Dept of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
PMID:
31699833
DOI:
10.1183/13993003.01681-2019
No abstract available
Publication types
Letter
MeSH terms
Fibrosis
Humans
Lung Diseases, Interstitial* / diagnosis
Oxygen
Substances
Oxygen
Grants and funding
20719/VAC_/Versus Arthritis/United Kingdom
PB-PG-0712-28073/DH_/Department of Health/United Kingdom